| Report ID | Date of report | Patient age | Patient gender |
| 54070 | Feb, 24, 2006 | 66 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Vioxx | rofecoxib |
Tylenol (caplet) | acetaminophen |
| Name |
Abdominal Pain |
Angina Pectoris |
Colour Blindness |
Diabetes Mellitus Non-insulin-dependent |
Diarrhoea |
Dizziness |
Dyspnoea |
Headache |
Hyperlipidaemia |
Hypertensive Heart Disease |
Hypoacusis |
Ischaemia |
Migraine |
Muscle Spasms |
Myocardial Infarction |
Non-cardiac Chest Pain |
Postnasal Drip |
Sinusitis |
Staphylococcal Infection |
Tinnitus |
Toe Deformity |
Transient Ischaemic Attack |
Visual Acuity Reduced |
Whiplash Injury |
Results from eHealthMe : 8110 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Abdominal Pain | 387 (4.77%) |
Angina Pectoris | 652 (8.04%) |
Colour Blindness | 1 (0.01%) |
Diabetes Mellitus Non-insulin-dependent | 109 (1.34%) |
Diarrhoea | 424 (5.23%) |
Dizziness | 787 (9.70%) |
Dyspnoea | 1010 (12.45%) |
Headache | 891 (10.99%) |
Hyperlipidaemia | 628 (7.74%) |
Hypertensive Heart Disease | 97 (1.20%) |
Hypoacusis | 28 (0.35%) |
Ischaemia | 136 (1.68%) |
Migraine | 455 (5.61%) |
Muscle Spasms | 218 (2.69%) |
Myocardial Infarction | 2672 (32.95%) |
Non-cardiac Chest Pain | 98 (1.21%) |
Postnasal Drip | 42 (0.52%) |
Sinusitis | 447 (5.51%) |
Staphylococcal Infection | 49 (0.60%) |
Tinnitus | 161 (1.99%) |
Toe Deformity | 29 (0.36%) |
Transient Ischaemic Attack | 837 (10.32%) |
Visual Acuity Reduced | 26 (0.32%) |
Whiplash Injury | 32 (0.39%) |
Top 3 (total: 1630. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Advil | 1038 (1.41%) |
Lipitor | 729 (0.99%) |
Celebrex | 704 (0.96%) |
Death reported: 181 (2.23% of total reports)
| Name | Count (% of total reports) |
Myocardial Infarction | 2672 (32.95%) |
Cerebrovascular Accident | 2244 (27.67%) |
Hypertension | 2075 (25.59%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
